420 related articles for article (PubMed ID: 33848261)
21. Empagliflozin repurposing in Parkinson's disease; modulation of oxidative stress, neuroinflammation, AMPK/SIRT-1/PGC-1α, and wnt/β-catenin pathways.
Mohammed NN; Tadros MG; George MY
Inflammopharmacology; 2024 Feb; 32(1):777-794. PubMed ID: 38038781
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of Wnt/β-catenin signaling attenuates axonal degeneration in models of Parkinson's disease.
Huang YL; Zhang JN; Hou TZ; Gu L; Yang HM; Zhang H
Neurochem Int; 2022 Oct; 159():105389. PubMed ID: 35809720
[TBL] [Abstract][Full Text] [Related]
23. Axin-2 knockdown promote mitochondrial biogenesis and dopaminergic neurogenesis by regulating Wnt/β-catenin signaling in rat model of Parkinson's disease.
Singh S; Mishra A; Mohanbhai SJ; Tiwari V; Chaturvedi RK; Khurana S; Shukla S
Free Radic Biol Med; 2018 Dec; 129():73-87. PubMed ID: 30176346
[TBL] [Abstract][Full Text] [Related]
24. Caffeine: An Overview of Its Beneficial Effects in Experimental Models and Clinical Trials of Parkinson's Disease.
Schepici G; Silvestro S; Bramanti P; Mazzon E
Int J Mol Sci; 2020 Jul; 21(13):. PubMed ID: 32635541
[TBL] [Abstract][Full Text] [Related]
25. Bruceine D elevates Nrf2 activation to restrain Parkinson's disease in mice through suppressing oxidative stress and inflammatory response.
Yang Y; Kong F; Ding Q; Cai Y; Hao Y; Tang B
Biochem Biophys Res Commun; 2020 Jun; 526(4):1013-1020. PubMed ID: 32321640
[TBL] [Abstract][Full Text] [Related]
26. The anti-aging protein klotho alleviates injury of nigrostriatal dopaminergic pathway in 6-hydroxydopamine rat model of Parkinson's disease: Involvement of PKA/CaMKII/CREB signaling.
Baluchnejadmojarad T; Eftekhari SM; Jamali-Raeufy N; Haghani S; Zeinali H; Roghani M
Exp Gerontol; 2017 Dec; 100():70-76. PubMed ID: 29107062
[TBL] [Abstract][Full Text] [Related]
27. Glycogen synthase kinase-3 beta (GSK-3β) signaling: Implications for Parkinson's disease.
Golpich M; Amini E; Hemmati F; Ibrahim NM; Rahmani B; Mohamed Z; Raymond AA; Dargahi L; Ghasemi R; Ahmadiani A
Pharmacol Res; 2015 Jul; 97():16-26. PubMed ID: 25829335
[TBL] [Abstract][Full Text] [Related]
28. Nrf2/Wnt resilience orchestrates rejuvenation of glia-neuron dialogue in Parkinson's disease.
Marchetti B
Redox Biol; 2020 Sep; 36():101664. PubMed ID: 32863224
[TBL] [Abstract][Full Text] [Related]
29. Neuroprotective potential of spermidine against rotenone induced Parkinson's disease in rats.
Sharma S; Kumar P; Deshmukh R
Neurochem Int; 2018 Jun; 116():104-111. PubMed ID: 29501454
[TBL] [Abstract][Full Text] [Related]
30. Neuroprotective effects of ginsenoside Rg1 through the Wnt/β-catenin signaling pathway in both in vivo and in vitro models of Parkinson's disease.
Zhou T; Zu G; Zhang X; Wang X; Li S; Gong X; Liang Z; Zhao J
Neuropharmacology; 2016 Feb; 101():480-9. PubMed ID: 26525190
[TBL] [Abstract][Full Text] [Related]
31. Neuroprotective strategies to prevent and treat Parkinson's disease based on its pathophysiological mechanism.
Lee Y; Kim MS; Lee J
Arch Pharm Res; 2017 Oct; 40(10):1117-1128. PubMed ID: 28952032
[TBL] [Abstract][Full Text] [Related]
32. Antioxidant and anti-inflammatory effects of dexrazoxane on dopaminergic neuron degeneration in rodent models of Parkinson's disease.
Mei M; Zhou Y; Liu M; Zhao F; Wang C; Ding J; Lu M; Hu G
Neuropharmacology; 2019 Dec; 160():107758. PubMed ID: 31494143
[TBL] [Abstract][Full Text] [Related]
33. Is cannabidiol the ideal drug to treat non-motor Parkinson's disease symptoms?
Crippa JAS; Hallak JEC; Zuardi AW; Guimarães FS; Tumas V; Dos Santos RG
Eur Arch Psychiatry Clin Neurosci; 2019 Feb; 269(1):121-133. PubMed ID: 30706171
[TBL] [Abstract][Full Text] [Related]
34. Neuroprotective effect of fasudil on inflammation through PI3K/Akt and Wnt/β-catenin dependent pathways in a mice model of Parkinson's disease.
Zhao Y; Zhang Q; Xi J; Xiao B; Li Y; Ma C
Int J Clin Exp Pathol; 2015; 8(3):2354-64. PubMed ID: 26045742
[TBL] [Abstract][Full Text] [Related]
35. A Comprehensive Review on Preclinical Evidence-based Neuroprotective Potential of
Goyal A; Gopika S; Kumar A; Garabadu D
Curr Drug Targets; 2022; 23(9):889-901. PubMed ID: 35297345
[TBL] [Abstract][Full Text] [Related]
36. The Chinese herbal formula Liuwei dihuang protects dopaminergic neurons against Parkinson's toxin through enhancing antioxidative defense and preventing apoptotic death.
Tseng YT; Chang FR; Lo YC
Phytomedicine; 2014 Apr; 21(5):724-33. PubMed ID: 24411708
[TBL] [Abstract][Full Text] [Related]
37. Vinpocetine improves dyskinesia in Parkinson's disease rats by reducing oxidative stress and activating the Wnt/β-catenin signaling pathway.
Ji M; Niu SQ; Mi HY; Jiang P; Li Y
Chem Biol Drug Des; 2024 Jan; 103(1):e14358. PubMed ID: 37749299
[TBL] [Abstract][Full Text] [Related]
38. Plant Polyphenols as Neuroprotective Agents in Parkinson's Disease Targeting Oxidative Stress.
Hor SL; Teoh SL; Lim WL
Curr Drug Targets; 2020; 21(5):458-476. PubMed ID: 31625473
[TBL] [Abstract][Full Text] [Related]
39. Neuroprotective effects of Astilbin on MPTP-induced Parkinson's disease mice: Glial reaction, α-synuclein expression and oxidative stress.
Zhu YL; Sun MF; Jia XB; Cheng K; Xu YD; Zhou ZL; Zhang PH; Qiao CM; Cui C; Chen X; Yang XS; Shen YQ
Int Immunopharmacol; 2019 Jan; 66():19-27. PubMed ID: 30419450
[TBL] [Abstract][Full Text] [Related]
40. Novel Targets for Parkinson's Disease: Addressing Different Therapeutic Paradigms and Conundrums.
Rane P; Sarmah D; Bhute S; Kaur H; Goswami A; Kalia K; Borah A; Dave KR; Sharma N; Bhattacharya P
ACS Chem Neurosci; 2019 Jan; 10(1):44-57. PubMed ID: 29957921
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
